前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写(冊子体のコピー)をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID:201702211198550995   整理番号:17A1189606

イングランドにおけるクロストリジウム・ディフィシレ感染制御介入の影響:観察研究【Powered by NICT】

Effects of control interventions on Clostridium difficile infection in England: an observational study
著者 (54件):
Dingle Kate E
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Dingle Kate E
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Dingle Kate E
(NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, UK)
Didelot Xavier
(Department of Infectious Disease Epidemiology, and NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London in partnership with Public Health England, Imperial College, London, London, UK)
Quan T Phuong
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Quan T Phuong
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Quan T Phuong
(NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, UK)
Eyre David W
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Eyre David W
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Stoesser Nicole
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Stoesser Nicole
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Golubchik Tanya
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Golubchik Tanya
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Harding Rosalind M
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Harding Rosalind M
(Department of Zoology, Oxford University, Oxford, UK)
Wilson Daniel J
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Wilson Daniel J
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Wilson Daniel J
(Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK)
Griffiths David
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Griffiths David
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Vaughan Alison
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Vaughan Alison
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Finney John M
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Finney John M
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Wyllie David H
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Wyllie David H
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Wyllie David H
(Public Health England Academic Collaborating Centre, Oxford, UK)
Oakley Sarah J
(Microbiology Department, Oxford University Hospitals NHS Trust, Oxford, UK)
Fawley Warren N
(Leeds Teaching Hospitals and University of Leeds, Department of Microbiology, Leeds General Infirmary, Leeds, UK)
Freeman Jane
(Leeds Teaching Hospitals and University of Leeds, Department of Microbiology, Leeds General Infirmary, Leeds, UK)
Morris Kirsti
(Leeds Teaching Hospitals and University of Leeds, Department of Microbiology, Leeds General Infirmary, Leeds, UK)
Martin Jessica
(Leeds Teaching Hospitals and University of Leeds, Department of Microbiology, Leeds General Infirmary, Leeds, UK)
Howard Philip
(Leeds Teaching Hospitals NHS Trust, Leeds, UK)
Gorbach Sherwood
(Cubist Pharmaceuticals, Lexington, MA, USA)
Gorbach Sherwood
(Tufts University School of Medicine, Boston, MA, USA)
Goldstein Ellie J C
(R M Alden Research Laboratory, Culver City, CA USA)
Citron Diane M
(R M Alden Research Laboratory, Culver City, CA USA)
Hopkins Susan
(NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, UK)
Hopkins Susan
(Healthcare-Associated Infection, Antimicrobial Resistance and Stewardship and Healthcare-Associated Infections Programme, Public Health England, London, UK)
Hopkins Susan
(Royal Free London NHS Foundation Trust and Public Health England, London, UK)
Hope Russell
(Department of Healthcare-Associated Infections and Antimicrobial Resistance, Centre for Infectious Disease Surveillance and Control, National Infection Service, Public Health England, London, UK)
Johnson Alan P
(NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, UK)
Johnson Alan P
(Department of Infectious Disease Epidemiology, and NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London in partnership with Public Health England, Imperial College, London, London, UK)
Johnson Alan P
(Department of Healthcare-Associated Infections and Antimicrobial Resistance, Centre for Infectious Disease Surveillance and Control, National Infection Service, Public Health England, London, UK)
Wilcox Mark H
(Leeds Teaching Hospitals and University of Leeds, Department of Microbiology, Leeds General Infirmary, Leeds, UK)
Peto Timothy E A
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Peto Timothy E A
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Peto Timothy E A
(NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, UK)
Walker A Sarah
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Walker A Sarah
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Walker A Sarah
(NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, UK)
Crook Derrick W
(Nuffield Department of Clinical Medicine, Oxford University, Oxford, UK)
Crook Derrick W
(National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK)
Crook Derrick W
(NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, UK)

資料名:
Lancet Infectious Diseases  (Lancet Infectious Diseases)

巻: 17  号:ページ: 411-421  発行年: 2017年 
JST資料番号: W3107A  ISSN: 1473-3099  資料種別: 逐次刊行物 (A)
記事区分: 原著論文  発行国: オランダ (NLD)  言語: 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写(コピー)して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写(コピー)は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。